Flomics Biotech, empresa biotecnológica dedicada a la genómica y la detección temprana del cáncer, ha cerrado una ronda de financiación privada de 1 millón de euros. Los fondos se utilizarán pa...
Leer másLa compañía se ha centrado en el estudio de ARN circulante para la detección precoz de cáncer
Leer másFlomics Biotech continues to dedicate resources in the battle against the COVID19 pandemic. Last year Flomics announced the release of -FlomicsCOVID19– a cloud-based Next Generation Sequencing (NGS)...
Leer másEl programa destinado a proyectos del sectorde la salud ha seleccionado a 3 startups españolas para Bridgehead Global y a 6 para Bridgehead Europe
Leer másFlomics Biotech, a startup from the Barcelona Biomedical Research Park (PRBB) and member of the Barcelona Health Hub (BHH) was selected among the most disruptive and innovative startups in the Health ...
Leer másFlomics Biotech, una startup del Parque de Investigación Biomédica de Barcelona (PRBB), que opera en el sector de la genómica y las biopsias líquidas, se complace en anunciar el lanzamiento de su ...
Leer másThe webinar will discuss opportunities for collaboration between Brazil and Europe in the area of Health. Fiocruz (Brazil), Aveiro University (Portugal) and Flomics Biotech (Spain) will discuss how CO...
Leer másOur world is dealing with a global pandemic that threatens life as we know it. The rapidly spreading coronavirus SARS-CoV-2 is a major public health emergency. Worldwide, scientists and healthcare pro...
Leer másFlomics is excited to announce a partnership with Lifebit in order to deploy an end-to-end cloud solution for COVID19 NGS data analysis. By combining Flomics’ expertise in NGS analysis with the f...
Leer másFlomics has joined forces with international biotech partners, specialized in Next Generation Sequencing tests, to develop a cloud-based data analysis solution for COVID19 detection and research.
Leer más